| Brand | Active ingredient | Application holder | Expiry | Excl. |
|---|---|---|---|---|
| ADLARITY | DONEPEZIL HYDROCHLORIDE | CORIUM LLC | 30 Dec | - |
| ADQUEY | DIFAMILAST | ACROTECH BIOPHARMA INC | 31 Dec | NCE |
| AIRDUO DIGIHALER | FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 14 Jun | - |
| AMBELVIST | GADOQUATRANE | BAYER HEALTHCARE PHARMACEUTICALS INC | 30 May | NCE |
| AMVUTTRA | VUTRISIRAN SODIUM | ALNYLAM PHARMACEUTICALS INC | 28 Jul | ODE-527 |
| ARAZLO | TAZAROTENE | BAUSCH HEALTH US LLC | 06 Jun | - |
| ARMONAIR DIGIHALER | FLUTICASONE PROPIONATE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 14 Jun | - |
| AUGTYRO | REPOTRECTINIB | BRISTOL MYERS SQUIBB CO | 05 Jul | ODE-483 |
| AUGTYRO | REPOTRECTINIB | BRISTOL MYERS SQUIBB CO | 20 Jul | ODE-483 |
| AUGTYRO | REPOTRECTINIB | BRISTOL MYERS SQUIBB CO | 24 Jul | ODE-483 |
| AUSTEDO | DEUTETRABENAZINE | TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D LLC | 07 Mar | - |
| AUSTEDO | DEUTETRABENAZINE | TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D LLC | 07 Sept | - |
| AUSTEDO XR | DEUTETRABENAZINE | TEVA NEUROSCIENCE INC | 07 Mar | - |
| AUSTEDO XR | DEUTETRABENAZINE | TEVA NEUROSCIENCE INC | 07 Sept | - |
| BALVERSA | ERDAFITINIB | JANSSEN BIOTECH INC | 09 Feb | I-930 |
| BALVERSA | ERDAFITINIB | JANSSEN BIOTECH INC | 13 Jun | I-930 |
| BALVERSA | ERDAFITINIB | JANSSEN BIOTECH INC | 13 Aug | I-930 |
| BAQSIMI | GLUCAGON | AMPHASTAR PHARMACEUTICALS INC | 16 Feb | NPP |
| BEIZRAY | DOCETAXEL | ZHUHAI BEIHAI BIOTECH CO LTD | 16 May | - |
| BIKTARVY | BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE | GILEAD SCIENCES INC | 08 Nov | ODE-540 |
| BLUDIGO | INDIGOTINDISULFONATE SODIUM | PROVEPHARM SAS | 25 Nov | NCE |
| BRILINTA | TICAGRELOR | ASTRAZENECA PHARMACEUTICALS LP | 27 Jan | - |
| BRILINTA | TICAGRELOR | ASTRAZENECA PHARMACEUTICALS LP | 27 Jul | - |
| BYQLOVI | CLOBETASOL PROPIONATE | HARROW EYE LLC | 09 May | NP |
| CALQUENCE | ACALABRUTINIB | ASTRAZENECA UK LTD | 01 Jul | D-200 |
| CAMZYOS | MAVACAMTEN | BRISTOL MYERS SQUIBB CO | 28 Apr | ODE-398 |
| CARDAMYST | ETRIPAMIL | MILESTONE PHARMACEUTICALS USA INC | 13 Apr | NCE |
| CAROSPIR | SPIRONOLACTONE | CMP DEVELOPMENT LLC | 28 Oct | - |
| CIBINQO | ABROCITINIB | PFIZER INC | 14 Jan | NCE |
| COMBOGESIC IV | ACETAMINOPHEN; IBUPROFEN SODIUM | HIKMA PHARMACEUTICALS USA INC | 14 Jan | NP |
| COTELLIC | COBIMETINIB FUMARATE | GENENTECH INC | 29 Jun | ODE-416 |
| COTELLIC | COBIMETINIB FUMARATE | GENENTECH INC | 30 Jun | ODE-416 |
| COTELLIC | COBIMETINIB FUMARATE | GENENTECH INC | 29 Dec | ODE-416 |
| COTELLIC | COBIMETINIB FUMARATE | GENENTECH INC | 30 Dec | ODE-416 |
| CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | DR REDDYS LABORATORIES INC | 15 Feb | - |
| CYSVIEW KIT | HEXAMINOLEVULINATE HYDROCHLORIDE | PHOTOCURE ASA | 19 Dec | - |
| DAURISMO | GLASDEGIB MALEATE | PFIZER INC | 13 Apr | - |
| DELSTRIGO | DORAVIRINE; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE | MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC | 29 Nov | - |
| DESCOVY | EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE | GILEAD SCIENCES INC | 29 Jun | ODE-556 |
| DEXMEDETOMIDINE HYDROCHLORIDE | DEXMEDETOMIDINE HYDROCHLORIDE | HQ SPECIALTY PHARMA CORP | 20 Apr | - |
| DEXTENZA | DEXAMETHASONE | OCULAR THERAPEUTIX INC | 07 Oct | NPP |
| DOCIVYX | DOCETAXEL | AVYXA HOLDINGS LLC | 14 Mar | - |
| DUOBRII | HALOBETASOL PROPIONATE; TAZAROTENE | BAUSCH HEALTH AMERICAS INC | 06 Jun | - |
| DUVYZAT | GIVINOSTAT HYDROCHLORIDE | ITALFARMACO SPA | 28 Oct | ODE-473 |
| DYANAVEL XR | AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE | TRIS PHARMA INC | 07 Sept | - |
| ELYXYB | CELECOXIB | SCILEX PHARMACEUTICALS INC | 27 May | - |
| ENTRESTO | SACUBITRIL; VALSARTAN | NOVARTIS PHARMACEUTICALS CORP | 09 May | - |
| EPANED | ENALAPRIL MALEATE | AZURITY PHARMACEUTICALS INC | 25 Mar | - |
| ESOMEPRAZOLE MAGNESIUM | ESOMEPRAZOLE MAGNESIUM | DEXCEL PHARMA TECHNOLOGIES LTD | 08 Dec | - |
| EVRYSDI | RISDIPLAM | GENENTECH INC | 25 Jan | ODE-400 |
| EVRYSDI | RISDIPLAM | GENENTECH INC | 08 Nov | ODE-400 |
| EXEM FOAM KIT | AIR POLYMER-TYPE A | GISKIT PHARMA BV | 11 Feb | - |
| EZALLOR SPRINKLE | ROSUVASTATIN CALCIUM | SUN PHARMACEUTICAL INDUSTRIES LTD | 12 Feb | - |
| FINTEPLA | FENFLURAMINE HYDROCHLORIDE | UCB INC | 20 Dec | PED |
| FYARRO | SIROLIMUS | AADI BIOSCIENCES INC | 05 Mar | ODE-386 |
| FYARRO | SIROLIMUS | AADI BIOSCIENCES INC | 29 Jun | ODE-386 |
| GALAFOLD | MIGALASTAT HYDROCHLORIDE | AMICUS THERAPEUTICS US LLC | 19 Jul | - |
| GAVRETO | PRALSETINIB | RIGEL PHARMACEUTICALS INC | 01 Nov | ODE-340 |
| GENOSYL | NITRIC OXIDE | VERO BIOTECH INC | 12 Feb | - |
| GLOPERBA | COLCHICINE | SCILEX PHARMACEUTICALS INC | 22 Nov | - |
| GVOKE HYPOPEN | GLUCAGON | XERIS PHARMACEUTICALS INC | 22 Apr | - |
| GVOKE KIT | GLUCAGON | XERIS PHARMACEUTICALS INC | 22 Apr | - |
| GVOKE PFS | GLUCAGON | XERIS PHARMACEUTICALS INC | 22 Apr | - |
| IBRANCE | PALBOCICLIB | PFIZER INC | 19 Aug | I-995 |
| IMBRUVICA | IBRUTINIB | PHARMACYCLICS LLC | 03 Mar | PED |
| IMBRUVICA | IBRUTINIB | PHARMACYCLICS LLC | 06 Apr | PED |
| IMBRUVICA | IBRUTINIB | PHARMACYCLICS LLC | 03 Sept | PED |
| IMMPHENTIV | PHENYLEPHRINE HYDROCHLORIDE | HIKMA PHARMACEUTICALS USA INC | 05 Aug | - |
| IMMPHENTIV | PHENYLEPHRINE HYDROCHLORIDE | HIKMA PHARMACEUTICALS USA INC | 26 Sept | - |
| INGREZZA | VALBENAZINE TOSYLATE | NEUROCRINE BIOSCIENCES INC | 28 Oct | ODE-440 |
| INGREZZA | VALBENAZINE TOSYLATE | NEUROCRINE BIOSCIENCES INC | 22 Dec | ODE-440 |
| INGREZZA SPRINKLE | VALBENAZINE TOSYLATE | NEUROCRINE BIOSCIENCES INC | 28 Oct | I-925 |
| INGREZZA SPRINKLE | VALBENAZINE TOSYLATE | NEUROCRINE BIOSCIENCES INC | 22 Dec | I-925 |
| INOMAX | NITRIC OXIDE | MALLINCKRODT PHARMACEUTICALS IRELAND LTD | 03 May | - |
| INOMAX | NITRIC OXIDE | MALLINCKRODT PHARMACEUTICALS IRELAND LTD | 03 Nov | - |
| INVEGA TRINZA | PALIPERIDONE PALMITATE | JANSSEN PHARMACEUTICALS INC | 05 Apr | - |
| ITOVEBI | INAVOLISIB | GENENTECH INC | 01 Jul | NCE |
| IVRA | MELPHALAN HYDROCHLORIDE | APOTEX INC | 29 Jun | - |
| IWILFIN | EFLORNITHINE HYDROCHLORIDE | USWM LLC | 12 Feb | ODE-462 |
| JAYPIRCA | PIRTOBRUTINIB | LOXO ONCOLOGY INC | 16 Dec | ODE-518 |
| KABIVEN IN PLASTIC CONTAINER | AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM GLYCEROPHOSPHATE; SOYBEAN OIL | FRESENIUS KABI USA LLC | 03 May | - |
| KISQALI | RIBOCICLIB SUCCINATE | NOVARTIS PHARMACEUTICALS CORP | 14 Apr | PED |
| KISQALI | RIBOCICLIB SUCCINATE | NOVARTIS PHARMACEUTICALS CORP | 14 Oct | PED |
| KISQALI FEMARA CO-PACK (COPACKAGED) | LETROZOLE; RIBOCICLIB SUCCINATE | NOVARTIS PHARMACEUTICALS CORP | 14 Apr | PED |
| KISQALI FEMARA CO-PACK (COPACKAGED) | LETROZOLE; RIBOCICLIB SUCCINATE | NOVARTIS PHARMACEUTICALS CORP | 14 Oct | PED |
| KOMZIFTI | ZIFTOMENIB | KURA ONCOLOGY INC | 16 Mar | NCE |
| KORLYM | MIFEPRISTONE | CORCEPT THERAPEUTICS INC | 20 Apr | - |
| KORLYM | MIFEPRISTONE | CORCEPT THERAPEUTICS INC | 12 Aug | - |
| KORLYM | MIFEPRISTONE | CORCEPT THERAPEUTICS INC | 15 Aug | - |
| KYGEVVI | DOXECITINE; DOXRIBTIMINE | UCB INC | 07 Aug | NCE |
| KYNMOBI | APOMORPHINE HYDROCHLORIDE | SUMITOMO PHARMA AMERICA INC | 19 Apr | - |
| LANSOPRAZOLE | LANSOPRAZOLE | DEXCEL PHARMA TECHNOLOGIES LTD | 21 Apr | - |
| LENVIMA | LENVATINIB MESYLATE | EISAI INC | 23 Feb | PED |
| LENVIMA | LENVATINIB MESYLATE | EISAI INC | 26 Feb | PED |
| LENVIMA | LENVATINIB MESYLATE | EISAI INC | 03 Mar | PED |
| LENVIMA | LENVATINIB MESYLATE | EISAI INC | 23 Aug | PED |
| LENVIMA | LENVATINIB MESYLATE | EISAI INC | 03 Sept | PED |
| LEQVIO | INCLISIRAN SODIUM | NOVARTIS PHARMACEUTICALS CORP | 25 Aug | ODE-555 |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | HIKMA PHARMACEUTICALS USA INC | 20 Jul | - |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | FRESENIUS KABI USA LLC | 01 Dec | - |
| LEVULAN | AMINOLEVULINIC ACID HYDROCHLORIDE | SUN PHARMACEUTICAL INDUSTRIES INC | 13 Oct | - |
| LEXETTE | HALOBETASOL PROPIONATE | MAYNE PHARMA LLC | 30 Nov | - |
| LOCAMETZ | GALLIUM GA-68 GOZETOTIDE | NOVARTIS PHARMACEUTICALS CORP | 09 Mar | - |
| LONHALA MAGNAIR KIT | GLYCOPYRROLATE | SUMITOMO PHARMA AMERICA INC | 12 Nov | - |
| LONHALA MAGNAIR KIT | GLYCOPYRROLATE | SUMITOMO PHARMA AMERICA INC | 07 Dec | - |
| LORBRENA | LORLATINIB | PFIZER INC | 27 Jul | ODE-349 |
| LOTEMAX SM | LOTEPREDNOL ETABONATE | BAUSCH AND LOMB INC | 26 Jan | - |
| LOTEMAX SM | LOTEPREDNOL ETABONATE | BAUSCH AND LOMB INC | 23 Dec | - |
| LYNKUET | ELINZANETANT | BAYER HEALTHCARE PHARMACEUTICALS INC | 18 May | NCE |
| LYTGOBI | FUTIBATINIB | TAIHO ONCOLOGY INC | 31 Mar | ODE-410 |
| MAVYRET | GLECAPREVIR; PIBRENTASVIR | ABBVIE INC | 24 Jun | PED |
| MAVYRET | GLECAPREVIR; PIBRENTASVIR | ABBVIE INC | 24 Dec | PED |
| MAYZENT | SIPONIMOD | NOVARTIS PHARMACEUTICALS CORP | 23 Apr | - |
| MIEBO | PERFLUOROHEXYLOCTANE | BAUSCH AND LOMB INC | 29 Sept | NCE |
| MINOLIRA | MINOCYCLINE HYDROCHLORIDE | EPI HEALTH LLC | 07 Apr | - |
| MODEYSO | DORDAVIPRONE HYDROCHLORIDE | CHIMERIX INC | 01 Mar | ODE-547 |
| MONOFERRIC | FERRIC DERISOMALTOSE | PHARMACOSMOS AS | 22 Jun | - |
| MOUNJARO | TIRZEPATIDE | ELI LILLY AND CO | 13 May | NPP |
| MOUNJARO (AUTOINJECTOR) | TIRZEPATIDE | ELI LILLY AND CO | 13 May | NPP |
| MOUNJARO KWIKPEN | TIRZEPATIDE | ELI LILLY AND CO | 13 May | NPP |
| MUCINEX 12HR COLD & FEVER MULTI-SYMPTOM | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; NAPROXEN SODIUM | RECKITT BENCKISER LLC | 11 Oct | - |
| MYCAPSSA | OCTREOTIDE ACETATE | CHIESI FARMACEUTICI SPA | 03 Feb | ODE-474 |
| MYRBETRIQ GRANULES | MIRABEGRON | ASTELLAS PHARMA GLOBAL DEVELOPMENT INC | 31 Mar | - |
| MYRBETRIQ GRANULES | MIRABEGRON | ASTELLAS PHARMA GLOBAL DEVELOPMENT INC | 30 Sept | - |
| NEREUS | TRADIPITANT | VANDA PHARMACEUTICALS INC | 04 Mar | NCE |
| NEREUS | TRADIPITANT | VANDA PHARMACEUTICALS INC | 09 Aug | NCE |
| NEXLETOL | BEMPEDOIC ACID | ESPERION THERAPEUTICS INC | 14 Mar | I-943 |
| NEXLIZET | BEMPEDOIC ACID; EZETIMIBE | ESPERION THERAPEUTICS INC | 14 Mar | I-943 |
| NEXTSTELLIS | DROSPIRENONE; ESTETROL | MAYNE PHARMA LLC | 17 Jun | NCE |
| NUBEQA | DAROLUTAMIDE | BAYER HEALTHCARE PHARMACEUTICALS INC | 28 Jan | I-971 |
| OCALIVA | OBETICHOLIC ACID | INTERCEPT PHARMACEUTICALS INC | 26 Apr | - |
| ODOMZO | SONIDEGIB PHOSPHATE | SUN PHARMACEUTICAL INDUSTRIES LTD | 30 Mar | - |
| OLPRUVA | SODIUM PHENYLBUTYRATE | ACER THERAPEUTICS INC | 17 Oct | - |
| OMEPRAZOLE | OMEPRAZOLE | DEXCEL PHARMA TECHNOLOGIES LTD | 08 Dec | - |
| ONIVYDE | IRINOTECAN HYDROCHLORIDE | IPSEN BIOPHARMACEUTICALS INC | 19 Aug | ODE-463 |
| ONIVYDE | IRINOTECAN HYDROCHLORIDE | IPSEN BIOPHARMACEUTICALS INC | 15 Oct | ODE-463 |
| OPFOLDA | MIGLUSTAT | AMICUS THERAPEUTICS US LLC | 29 Dec | NP |
| ORGOVYX | RELUGOLIX | SUMITOMO PHARMA AMERICA INC | 25 Feb | - |
| ORILISSA | ELAGOLIX SODIUM | ABBVIE INC | 01 Sept | - |
| ORSERDU | ELACESTRANT HYDROCHLORIDE | STEMLINE THERAPEUTICS INC | 03 Oct | NCE |
| ORTIKOS | BUDESONIDE | SUN PHARMACEUTICAL INDUSTRIES INC | 09 Sept | - |
| OXBRYTA | VOXELOTOR | GLOBAL BLOOD THERAPEUTICS INC | 02 Dec | ODE-394 |
| PEMFEXY | PEMETREXED | EAGLE PHARMACEUTICALS INC | 19 Feb | - |
| PERIKABIVEN IN PLASTIC CONTAINER | AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM GLYCEROPHOSPHATE; SOYBEAN OIL | FRESENIUS KABI USA LLC | 03 May | - |
| PLUVICTO | LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN | NOVARTIS PHARMACEUTICALS CORP | 23 Mar | I-965 |
| PROCYSBI | CYSTEAMINE BITARTRATE | HORIZON THERAPEUTICS USA INC | 16 Aug | - |
| QFITLIA | FITUSIRAN SODIUM | GENZYME CORP | 07 Dec | ODE-510 |
| REZZAYO | REZAFUNGIN ACETATE | MUNDIPHARMA GMBH | 09 May | GAIN |
| RINVOQ | UPADACITINIB | ABBVIE INC | 17 Oct | ODE-481 |
| RINVOQ LQ | UPADACITINIB | ABBVIE INC | 17 Oct | ODE-481 |
| SPINRAZA | NUSINERSEN SODIUM | BIOGEN INC | 04 Mar | - |
| SYFOVRE | PEGCETACOPLAN | APELLIS PHARMACEUTICALS INC | 07 Oct | NCE |
| SYMBRAVO | MELOXICAM; RIZATRIPTAN BENZOATE | AXSOME THERAPEUTICS INC | 11 Apr | NP |
| SYMJEPI | EPINEPHRINE | ADAMIS PHARMACEUTICALS CORP | 20 Oct | - |
| TASCENSO ODT | FINGOLIMOD LAURYL SULFATE | CYCLE PHARMACEUTICALS LTD | 19 Jan | - |
| TIBSOVO | IVOSIDENIB | SERVIER PHARMACEUTICALS LLC | 18 Oct | ODE-447 |
| TRUDHESA | DIHYDROERGOTAMINE MESYLATE | IMPEL PHARMACEUTICALS LLC | 05 Nov | - |
| TURALIO | PEXIDARTINIB HYDROCHLORIDE | DAIICHI SANKYO INC | 05 May | ODE* |
| UPTRAVI | SELEXIPAG | ACTELION PHARMACEUTICALS US INC | 01 Dec | PED |
| VAFSEO | VADADUSTAT | AKEBIA THERAPEUTICS INC | 31 Mar | NCE |
| VEKLURY | REMDESIVIR | GILEAD SCIENCES INC | 29 Apr | PED |
| VEKLURY | REMDESIVIR | GILEAD SCIENCES INC | 16 Sept | PED |
| VELSIPITY | ETRASIMOD ARGININE | PFIZER INC | 06 Jan | NCE |
| VELSIPITY | ETRASIMOD ARGININE | PFIZER INC | 21 Jun | NCE |
| VEVYE | CYCLOSPORINE | HARROW EYE LLC | 29 Sept | NP |
| VITRAKVI | LAROTRECTINIB SULFATE | BAYER HEALTHCARE PHARMACEUTICALS INC | 15 Aug | - |
| VIVJOA | OTESECONAZOLE | MYCOVIA PHARMACEUTICALS INC | 17 Mar | GAIN |
| VOXZOGO | VOSORITIDE | BIOMARIN PHARMACEUTICAL INC | 01 Aug | ODE-449 |
| VTAMA | TAPINAROF | ORGANON LLC | 19 May | I-956 |
| VTAMA | TAPINAROF | ORGANON LLC | 23 May | I-956 |
| WELIREG | BELZUTIFAN | MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC | 14 Apr | I-994 |
| XACIATO | CLINDAMYCIN PHOSPHATE | ORGANON LLC | 22 Sept | GAIN |
| XENLETA | LEFAMULIN ACETATE | HONG KONG KING FRIEND INDUSTRIAL CO LTD | 14 Jun | GAIN |
| XHANCE | FLUTICASONE PROPIONATE | PARATEK PHARMACEUTICALS INC | 23 Feb | I-940 |
| XOFLUZA | BALOXAVIR MARBOXIL | GENENTECH INC | 27 Apr | M-187 |
| XOLREMDI | MAVORIXAFOR | X4 PHARMACEUTICALS INC | 14 Dec | ODE-480 |
| XOLREMDI | MAVORIXAFOR | X4 PHARMACEUTICALS INC | 22 Dec | ODE-480 |
| XOSPATA | GILTERITINIB FUMARATE | ASTELLAS PHARMA US INC | 01 Jul | - |
| XTAMPZA ER | OXYCODONE | COLLEGIUM PHARMACEUTICAL INC | 02 Sept | - |
| XYOSTED (AUTOINJECTOR) | TESTOSTERONE ENANTHATE | ANTARES PHARMA INC | 04 Sept | - |
| ZEMBRACE SYMTOUCH | SUMATRIPTAN SUCCINATE | TONIX MEDICINES INC | 29 Jan | - |
| ZEPBOUND | TIRZEPATIDE | ELI LILLY AND CO | 13 May | I-958 |
| ZEPBOUND (AUTOINJECTOR) | TIRZEPATIDE | ELI LILLY AND CO | 13 May | I-958 |
| ZEPBOUND KWIKPEN | TIRZEPATIDE | ELI LILLY AND CO | 13 May | I-958 |
| ZERBAXA | CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM | CUBIST PHARMACEUTICALS LLC | 14 Feb | PED |
| ZOLYMBUS | BIMATOPROST | THEA PHARMA INC | 08 Jun | NDF |
| ZURAGARD | ISOPROPYL ALCOHOL | ZUREX PHARMA | 24 Apr | - |
| ZYNRELEF KIT | BUPIVACAINE; MELOXICAM | HERON THERAPEUTICS INC | 21 Apr | I-933 |
Provenance
Source: FDA Orange Book patent and exclusivity files. Rows carrying an exclusivity code have a separate regulatory exclusivity that can outlast the patent shown. Patent expiry alone does not determine when a generic can launch: paediatric extensions, 30-month stays and settlement agreements frequently move the effective date. Delisted patents are excluded.